Skip to content

AtriCure ATRC Return on equity

Return on equity at other companies

Abbott logo
AbbottABT
12.4%-18.4pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%-3.0pp
Boston Scientific logo
Boston ScientificBSX
14.8%+5.2pp
Medtronic logo
MedtronicMDT
9.8%+0.4pp
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
-80.7%+3.1pp
ITG
Integer HoldingsITGR
8.6%+3.7pp

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-9.9%
Enterprise value$1.36B-13.1%
P/S2.6×-0.7×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Calculated from AtriCure’s reported figures.

Based on trailing twelve months.

The official record: AtriCure’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's return on equity?
AtriCure (ATRC) reported return on equity of -6.1% in Q3 2025.
How has AtriCure's return on equity changed year-over-year?
AtriCure's return on equity increased by 27.1% year-over-year, from -8.4% to -6.1%.
What is the long-term trend for AtriCure's return on equity?
Over 3 years (2020 to 2024), AtriCure's return on equity has grown at a -12.9% compound annual growth rate (CAGR), from -14.6% to -9.6%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.